Related Experiment Video
Updated: Aug 20, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Synthetic approaches to the 2003 new drugs
Kevin K-C Liu1, Jin Li, Subas Sakya
1Pfizer Global Research and Development, Pfizer Inc, Groton, CT 06340, USA. kevin_k_liu@groton.pfizer.com
Abstract:
New drugs are introduced to the market every year and each individual drug represents a privileged structure for its biological target. In addition, these new chemical entities (NCEs) not only provide insights into molecular recognition, but also serve as drug-like leads for designing new future drugs. To these ends, this review covers the syntheses of 23 NCEs marketed in 2003.
Related Concept Videos
Drug Discovery: Overview
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Drug Regulation
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets
Prodrugs
Prodrugs help overcome...

